Beacon Biosignals

Beacon Biosignals

Beacon Biosignals

neurobiomarker discovery & computational diagnostics for precision neurology & psychiatry
Type
B2c
Founded
2019
Raised
$27M
Follow us
Alexa global traffic share
Latest funding
$27,000,000
Venture capital (Series A) - 2021
Casdin Capital General Catalyst Andrew Beck
Team Size
1–10
Employees
$27,000,000 Venture capital (Series A)
MedCity News

Neurotech startup Beacon Biosignals scores $27M to bring AI to EEG analysis